Related Experiment Videos
ACE-inhibitors: panacea for progressive renal disease
G Navis1, D de Zeeuw, P E de Jong
1Division of Nephrology, University Hospital Groningen, Netherlands.
Lancet (London, England)
|June 28, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association·2018
Biomarkers of Renal Function: Towards Clinical Actionability.
Clinical pharmacology and therapeutics·2017
Comparison of urine collection methods for albuminuria assessment in young children.
Clinica chimica acta; international journal of clinical chemistry·2016
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.
Diabetes, obesity & metabolism·2015
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.
Diabetes, obesity & metabolism·2015
Seedless 3' pairing enables miR-17 family miRNAs to seize let-7 target sites.
Nucleic acids research·2026
Computationally Evidence-Grounded Sequence-First Design of Peptide Binders.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Aroma-Platins: A Modular Extended-Aromatic β-Diketonate Platinum(II) Platform for Tunable Activation and Anticancer Activity.
Chemistry (Weinheim an der Bergstrasse, Germany)·2026
The assembly of synthetically difficult "drug-like" macrocyclic peptides.
Chemical communications (Cambridge, England)·2026
Growth inhibition of hepatocellular carcinoma by the polysaccharide-protein complex from Inonotus hispidus mycelia and the mechanisms.
Journal of the science of food and agriculture·2026